Stockreport

Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio [Yahoo! Finance]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio's novel antibody-dr [Read more]